Design Therapeutics (DSGN)
Nasdaq • DSGN • US25056L1035
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 19.3% of free float sold short, 13.1 days to cover, cost to borrow 0.55%. Sign up for live short interest data.
Market Cap
639m USD | # 5654 in US
Volume
581.32k shares | 7.44m USD
Shares Outstanding
62.58m
Free Float Shares
57.83% | 36.19m
